The FDA was in the middle of a Pandemic where they
Post# of 145753
![](/assets/46931549/no_avatar_available_thumb.jpg)
https://www.amarexcro.com/news/amarex-co-auth...ovid-paper
I would say that the FDA position as stated: "If CytoDyn plans further studies of leronlimab to determine whether the drug can provide clinical benefit to individuals with COVID-19, FDA will continue to provide advice to the company on their development program."
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)